name	nAnno	nOverlap	fc	zscore	pvalue	adjp	or	CIl	CIu
R-HSA-8953854	Metabolism of RNA	646	113	3.49	15	4.9e-34	2.4e-31	4.89	3.86	6.16
R-HSA-72766	Translation	258	52	4.02	11.3	1.9e-18	4.8e-16	5.22	3.72	7.22
R-HSA-5419276	Mitochondrial translation termination	86	29	6.73	12.3	4.3e-17	7.1e-15	10.2	6.2	16.3
R-HSA-5368287	Mitochondrial translation	87	29	6.65	12.2	6.1e-17	7.6e-15	9.99	6.1	16
R-HSA-5389840	Mitochondrial translation elongation	84	28	6.65	11.9	2.1e-16	2.1e-14	9.97	6.04	16.1
R-HSA-392499	Metabolism of proteins	1907	170	1.78	8.68	4.7e-16	3.8e-14	2.29	1.88	2.79
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	243	43	3.53	9.17	2.5e-13	1.8e-11	4.36	3.02	6.18
R-HSA-191859	snRNP Assembly	52	19	7.29	10.4	2.3e-12	1.3e-10	11.3	6.02	20.6
R-HSA-194441	Metabolism of non-coding RNA	52	19	7.29	10.4	2.3e-12	1.3e-10	11.3	6.02	20.6
R-HSA-162906	HIV Infection	184	35	3.79	8.79	5.4e-12	2.7e-10	4.71	3.12	6.93
R-HSA-72172	mRNA Splicing	191	35	3.66	8.51	1.6e-11	7.4e-10	4.49	2.99	6.61
R-HSA-69206	G1/S Transition	124	27	4.34	8.61	6.1e-11	2.5e-09	5.51	3.42	8.62
R-HSA-72163	mRNA Splicing - Major Pathway	183	33	3.6	8.15	9.9e-11	3.8e-09	4.39	2.88	6.52
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	63	19	6.02	9.17	1.1e-10	4e-09	8.46	4.63	14.9
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	59	18	6.09	9	2.8e-10	9.3e-09	8.59	4.61	15.4
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	67	19	5.66	8.79	3.7e-10	1.1e-08	7.75	4.27	13.6
R-HSA-69239	Synthesis of DNA	99	23	4.63	8.35	4.2e-10	1.1e-08	5.96	3.53	9.71
R-HSA-453279	Mitotic G1-G1/S phases	143	28	3.91	8.04	3.8e-10	1.1e-08	4.83	3.04	7.43
R-HSA-180585	Vif-mediated degradation of APOBEC3G	54	17	6.28	8.94	5.1e-10	1.3e-08	8.97	4.7	16.5
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	54	17	6.28	8.94	5.1e-10	1.3e-08	8.97	4.7	16.5
R-HSA-68874	M/G1 Transition	85	21	4.93	8.35	7.2e-10	1.6e-08	6.44	3.7	10.8
R-HSA-69002	DNA Replication Pre-Initiation	85	21	4.93	8.35	7.2e-10	1.6e-08	6.44	3.7	10.8
R-HSA-162909	Host Interactions of HIV factors	128	26	4.05	7.98	7e-10	1.6e-08	5.04	3.11	7.9
R-HSA-5610780	Degradation of GLI1 by the proteasome	57	17	5.95	8.61	1.3e-09	2.7e-08	8.3	4.38	15.1
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	72	19	5.26	8.34	1.4e-09	2.7e-08	7.02	3.89	12.2
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	72	19	5.26	8.34	1.4e-09	2.7e-08	7.02	3.89	12.2
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	80	20	4.99	8.22	1.5e-09	2.7e-08	6.53	3.7	11.1
R-HSA-69620	Cell Cycle Checkpoints	292	41	2.8	7.17	1.6e-09	2.9e-08	3.28	2.27	4.65
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	73	19	5.19	8.26	1.8e-09	3.1e-08	6.89	3.82	11.9
R-HSA-195253	Degradation of beta-catenin by the destruction complex	81	20	4.92	8.15	1.9e-09	3.1e-08	6.43	3.64	10.9
R-HSA-8953897	Cellular responses to external stimuli	493	57	2.31	6.83	2e-09	3.2e-08	2.67	1.95	3.58
R-HSA-180534	Vpu mediated degradation of CD4	52	16	6.14	8.53	2.4e-09	3.6e-08	8.66	4.45	16.1
R-HSA-8939902	Regulation of RUNX2 expression and activity	59	17	5.75	8.4	2.4e-09	3.6e-08	7.9	4.18	14.3
R-HSA-69306	DNA Replication	108	23	4.25	7.8	2.6e-09	3.8e-08	5.32	3.17	8.61
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	75	19	5.05	8.09	3e-09	4.2e-08	6.64	3.69	11.5
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	60	17	5.65	8.3	3.2e-09	4.4e-08	7.72	4.09	13.9
R-HSA-68867	Assembly of the pre-replicative complex	68	18	5.28	8.14	3.6e-09	4.8e-08	7.03	3.83	12.4
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	76	19	4.99	8.01	3.8e-09	4.8e-08	6.52	3.63	11.2
R-HSA-69242	S Phase	138	26	3.76	7.49	3.8e-09	4.8e-08	4.58	2.84	7.15
R-HSA-6807070	PTEN Regulation	140	26	3.7	7.4	5.3e-09	6.5e-08	4.5	2.79	7.02
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	86	20	4.64	7.79	5.8e-09	6.8e-08	5.94	3.38	10
R-HSA-453276	Regulation of mitotic cell cycle	86	20	4.64	7.79	5.8e-09	6.8e-08	5.94	3.38	10
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	55	16	5.8	8.2	6.1e-09	7e-08	7.99	4.14	14.8
R-HSA-68949	Orc1 removal from chromatin	71	18	5.06	7.88	7.7e-09	8.5e-08	6.63	3.63	11.6
R-HSA-69052	Switching of origins to a post-replicative state	71	18	5.06	7.88	7.7e-09	8.5e-08	6.63	3.63	11.6
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	50	15	5.98	8.12	1.1e-08	1.2e-07	8.34	4.2	15.8
R-HSA-4641258	Degradation of DVL	57	16	5.6	8	1.1e-08	1.2e-07	7.6	3.95	14
R-HSA-69300	Removal of licensing factors from origins	73	18	4.92	7.72	1.2e-08	1.3e-07	6.39	3.5	11.2
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	51	15	5.87	8	1.5e-08	1.5e-07	8.1	4.09	15.3
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	51	15	5.87	8	1.5e-08	1.5e-07	8.1	4.09	15.3
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	51	15	5.87	8	1.5e-08	1.5e-07	8.1	4.09	15.3
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	51	15	5.87	8	1.5e-08	1.5e-07	8.1	4.09	15.3
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	66	17	5.14	7.75	1.6e-08	1.5e-07	6.76	3.62	12.1
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	52	15	5.75	7.9	2.1e-08	1.7e-07	7.88	3.99	14.8
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	52	15	5.75	7.9	2.1e-08	1.7e-07	7.88	3.99	14.8
R-HSA-69610	p53-Independent DNA Damage Response	52	15	5.75	7.9	2.1e-08	1.7e-07	7.88	3.99	14.8
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	52	15	5.75	7.9	2.1e-08	1.7e-07	7.88	3.99	14.8
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	59	16	5.41	7.8	1.9e-08	1.7e-07	7.25	3.78	13.2
R-HSA-72306	tRNA processing	83	19	4.57	7.49	1.8e-08	1.7e-07	5.8	3.26	9.91
R-HSA-2467813	Separation of Sister Chromatids	191	30	3.13	6.84	2.1e-08	1.7e-07	3.69	2.39	5.54
R-HSA-68882	Mitotic Anaphase	202	31	3.06	6.8	2.1e-08	1.7e-07	3.59	2.34	5.36
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	60	16	5.32	7.71	2.4e-08	1.9e-07	7.08	3.7	12.9
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	60	16	5.32	7.71	2.4e-08	1.9e-07	7.08	3.7	12.9
R-HSA-69304	Regulation of DNA replication	76	18	4.72	7.49	2.5e-08	1.9e-07	6.06	3.33	10.5
R-HSA-2555396	Mitotic Metaphase and Anaphase	203	31	3.05	6.77	2.4e-08	1.9e-07	3.57	2.33	5.33
R-HSA-73776	RNA Polymerase II Promoter Escape	47	14	5.94	7.8	3.9e-08	2.8e-07	8.24	4.04	15.9
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	47	14	5.94	7.8	3.9e-08	2.8e-07	8.24	4.04	15.9
R-HSA-75953	RNA Polymerase II Transcription Initiation	47	14	5.94	7.8	3.9e-08	2.8e-07	8.24	4.04	15.9
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	47	14	5.94	7.8	3.9e-08	2.8e-07	8.24	4.04	15.9
R-HSA-4641257	Degradation of AXIN	55	15	5.44	7.59	4.8e-08	3.3e-07	7.29	3.71	13.6
R-HSA-8941858	Regulation of RUNX3 expression and activity	55	15	5.44	7.59	4.8e-08	3.3e-07	7.29	3.71	13.6
R-HSA-8878166	Transcriptional regulation by RUNX2	80	18	4.49	7.2	5.8e-08	4e-07	5.67	3.13	9.79
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	56	15	5.34	7.49	6.2e-08	4.2e-07	7.11	3.63	13.2
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	56	15	5.34	7.49	6.2e-08	4.2e-07	7.11	3.63	13.2
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	81	18	4.43	7.13	7.1e-08	4.7e-07	5.58	3.08	9.63
R-HSA-69541	Stabilization of p53	57	15	5.25	7.39	8.1e-08	5.3e-07	6.94	3.55	12.9
R-HSA-69202	Cyclin E associated events during G1/S transition 	82	18	4.38	7.06	8.7e-08	5.6e-07	5.49	3.04	9.47
R-HSA-1169091	Activation of NF-kappaB in B cells	66	16	4.84	7.18	1e-07	6.6e-07	6.23	3.29	11.2
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	75	17	4.52	7.03	1.2e-07	7.4e-07	5.71	3.09	10
R-HSA-2262749	Cellular response to hypoxia	75	17	4.52	7.03	1.2e-07	7.4e-07	5.71	3.09	10
R-HSA-5663205	Infectious disease	326	40	2.45	6.1	1.2e-07	7.4e-07	2.79	1.93	3.96
R-HSA-5387390	Hh mutants abrogate ligand secretion	59	15	5.07	7.21	1.3e-07	8e-07	6.62	3.4	12.2
R-HSA-5658442	Regulation of RAS by GAPs	68	16	4.69	7.02	1.6e-07	9.8e-07	5.99	3.17	10.7
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	86	18	4.17	6.79	1.9e-07	1.1e-06	5.16	2.87	8.86
R-HSA-5678895	Defective CFTR causes cystic fibrosis	61	15	4.9	7.03	2.1e-07	1.2e-06	6.33	3.26	11.7
R-HSA-8948751	Regulation of PTEN stability and activity	69	16	4.63	6.94	2e-07	1.2e-06	5.87	3.11	10.5
R-HSA-69481	G2/M Checkpoints	167	26	3.11	6.3	2.2e-07	1.2e-06	3.63	2.27	5.61
R-HSA-8951664	Neddylation	235	32	2.72	6.12	2.2e-07	1.2e-06	3.12	2.06	4.61
R-HSA-4608870	Asymmetric localization of PCP proteins	62	15	4.83	6.94	2.7e-07	1.5e-06	6.2	3.2	11.4
R-HSA-74160	Gene expression (Transcription)	1335	107	1.6	5.4	2.8e-07	1.5e-06	1.83	1.45	2.29
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	80	17	4.24	6.68	3.3e-07	1.8e-06	5.26	2.86	9.18
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	118	21	3.55	6.4	3.4e-07	1.8e-06	4.24	2.49	6.91
R-HSA-5358346	Hedgehog ligand biogenesis	64	15	4.67	6.78	4.2e-07	2.2e-06	5.95	3.07	10.9
R-HSA-6784531	tRNA processing in the nucleus	56	14	4.99	6.87	4.4e-07	2.3e-06	6.46	3.24	12.2
R-HSA-69563	p53-Dependent G1 DNA Damage Response	66	15	4.53	6.62	6.5e-07	3.3e-06	5.71	2.96	10.4
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	66	15	4.53	6.62	6.5e-07	3.3e-06	5.71	2.96	10.4
R-HSA-351202	Metabolism of polyamines	84	17	4.04	6.42	6.8e-07	3.4e-06	4.94	2.7	8.59
R-HSA-674695	RNA Polymerase II Pre-transcription Events	84	17	4.04	6.42	6.8e-07	3.4e-06	4.94	2.7	8.59
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	23	9	7.81	7.51	8.1e-07	4e-06	12.4	4.7	30.9
R-HSA-72312	rRNA processing	201	28	2.78	5.85	8e-07	4e-06	3.19	2.04	4.83
R-HSA-69615	G1/S DNA Damage Checkpoints	68	15	4.4	6.46	9.8e-07	4.8e-06	5.49	2.85	9.98
R-HSA-72165	mRNA Splicing - Minor Pathway	52	13	4.99	6.62	1.1e-06	5.5e-06	6.45	3.14	12.5
R-HSA-2871837	FCERI mediated NF-kB activation	79	16	4.04	6.23	1.4e-06	6.9e-06	4.94	2.64	8.73
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	165	24	2.9	5.66	2.3e-06	1.1e-05	3.34	2.05	5.23
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	84	16	3.8	5.92	3.4e-06	1.6e-05	4.57	2.45	8.04
R-HSA-5632684	Hedgehog 'on' state	85	16	3.75	5.86	4e-06	1.9e-05	4.5	2.42	7.91
R-HSA-5607764	CLEC7A (Dectin-1) signaling	96	17	3.53	5.73	4.8e-06	2.2e-05	4.18	2.3	7.2
R-HSA-69278	Cell Cycle, Mitotic	531	51	1.92	4.98	4.9e-06	2.2e-05	2.13	1.54	2.89
R-HSA-379724	tRNA Aminoacylation	35	10	5.7	6.4	5.4e-06	2.4e-05	7.71	3.28	16.7
R-HSA-1632852	Macroautophagy	68	14	4.11	5.91	5.3e-06	2.4e-05	5.02	2.56	9.25
R-HSA-5689603	UCH proteinases	97	17	3.5	5.67	5.5e-06	2.4e-05	4.13	2.28	7.1
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	310	35	2.25	5.14	5.3e-06	2.4e-05	2.52	1.7	3.64
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	11	6	10.9	7.53	5.7e-06	2.5e-05	23	5.82	95.4
R-HSA-1640170	Cell Cycle	607	56	1.84	4.91	5.6e-06	2.5e-05	2.04	1.5	2.74
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	78	15	3.84	5.78	6e-06	2.6e-05	4.62	2.42	8.28
R-HSA-1236975	Antigen processing-Cross presentation	88	16	3.63	5.69	6.4e-06	2.7e-05	4.31	2.32	7.56
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	79	15	3.79	5.71	7.1e-06	3e-05	4.55	2.39	8.14
R-HSA-2262752	Cellular responses to stress	425	43	2.02	4.93	7.8e-06	3.2e-05	2.24	1.57	3.12
R-HSA-73857	RNA Polymerase II Transcription	1230	95	1.54	4.65	7.6e-06	3.2e-05	1.72	1.35	2.18
R-HSA-5696398	Nucleotide Excision Repair	111	18	3.23	5.44	9.1e-06	3.8e-05	3.76	2.12	6.35
R-HSA-8868773	rRNA processing in the nucleus and cytosol	191	25	2.61	5.16	9.6e-06	3.9e-05	2.95	1.84	4.56
R-HSA-5619084	ABC transporter disorders	81	15	3.69	5.59	9.8e-06	4e-05	4.41	2.32	7.87
R-HSA-9020702	Interleukin-1 signaling	102	17	3.32	5.42	1.1e-05	4.5e-05	3.89	2.15	6.66
R-HSA-5610787	Hedgehog 'off' state	113	18	3.18	5.35	1.2e-05	4.7e-05	3.69	2.08	6.2
R-HSA-69275	G2/M Transition	195	25	2.56	5.04	1.4e-05	5.5e-05	2.88	1.79	4.45
R-HSA-382556	ABC-family proteins mediated transport	104	17	3.26	5.32	1.4e-05	5.7e-05	3.8	2.1	6.5
R-HSA-453274	Mitotic G2-G2/M phases	197	25	2.53	4.99	1.7e-05	6.4e-05	2.85	1.77	4.4
R-HSA-611105	Respiratory electron transport	95	16	3.36	5.31	1.8e-05	6.8e-05	3.93	2.13	6.85
R-HSA-71291	Metabolism of amino acids and derivatives	251	29	2.3	4.81	2.2e-05	8.4e-05	2.56	1.66	3.84
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	67	13	3.87	5.42	2.3e-05	8.6e-05	4.65	2.31	8.71
R-HSA-73856	RNA Polymerase II Transcription Termination	67	13	3.87	5.42	2.3e-05	8.6e-05	4.65	2.31	8.71
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	108	17	3.14	5.14	2.4e-05	9e-05	3.63	2.01	6.19
R-HSA-202424	Downstream TCR signaling	98	16	3.26	5.16	2.6e-05	9.7e-05	3.78	2.05	6.58
R-HSA-1257604	PIP3 activates AKT signaling	254	29	2.28	4.74	2.8e-05	1e-04	2.53	1.64	3.78
R-HSA-597592	Post-translational protein modification	1353	100	1.47	4.31	2.7e-05	1e-04	1.64	1.29	2.06
R-HSA-4086400	PCP/CE pathway	89	15	3.36	5.14	3.2e-05	0.00011	3.93	2.08	6.97
R-HSA-5687128	MAPK6/MAPK4 signaling	89	15	3.36	5.14	3.2e-05	0.00011	3.93	2.08	6.97
R-HSA-3700989	Transcriptional Regulation by TP53	365	37	2.02	4.57	3.3e-05	0.00012	2.23	1.52	3.18
R-HSA-983169	Class I MHC mediated antigen processing & presentation	365	37	2.02	4.57	3.3e-05	0.00012	2.23	1.52	3.18
R-HSA-162587	HIV Life Cycle	101	16	3.16	5.01	3.8e-05	0.00013	3.65	1.98	6.33
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	182	23	2.52	4.76	3.8e-05	0.00013	2.82	1.72	4.44
R-HSA-5696395	Formation of Incision Complex in GG-NER	43	10	4.64	5.49	3.9e-05	0.00014	5.83	2.55	12.2
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	102	16	3.13	4.96	4.4e-05	0.00015	3.61	1.96	6.26
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	28	8	5.7	5.72	4.8e-05	0.00017	7.68	2.91	18.3
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	10	5	9.97	6.52	6.3e-05	0.00022	19.1	4.38	83.1
R-HSA-72086	mRNA Capping	29	8	5.5	5.58	6.4e-05	0.00022	7.32	2.79	17.3
R-HSA-6799198	Complex I biogenesis	55	11	3.99	5.11	7.2e-05	0.00024	4.82	2.23	9.56
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	65	12	3.68	4.98	7.8e-05	0.00026	4.37	2.11	8.35
R-HSA-9006925	Intracellular signaling by second messengers	282	30	2.12	4.39	7.6e-05	0.00026	2.34	1.53	3.46
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	30	8	5.32	5.44	8.3e-05	0.00027	6.98	2.67	16.4
R-HSA-1430728	Metabolism	1899	129	1.35	3.95	8.6e-05	0.00028	1.51	1.22	1.87
R-HSA-6782135	Dual incision in TC-NER	66	12	3.63	4.92	9.1e-05	3e-04	4.29	2.07	8.18
R-HSA-162599	Late Phase of HIV Life Cycle	88	14	3.17	4.7	0.00011	0.00036	3.66	1.89	6.59
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	68	12	3.52	4.79	0.00012	4e-04	4.13	2	7.87
R-HSA-68886	M Phase	391	37	1.89	4.11	0.00014	0.00045	2.06	1.41	2.93
R-HSA-5696400	Dual Incision in GG-NER	41	9	4.38	4.98	0.00015	0.00049	5.41	2.26	11.7
R-HSA-113418	Formation of the Early Elongation Complex	33	8	4.84	5.07	0.00017	0.00054	6.14	2.38	14.1
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	126	17	2.69	4.39	0.00018	0.00055	3.02	1.69	5.12
R-HSA-446652	Interleukin-1 family signaling	138	18	2.6	4.35	0.00018	0.00055	2.91	1.65	4.85
R-HSA-1852241	Organelle biogenesis and maintenance	269	28	2.08	4.11	0.00019	0.00059	2.27	1.46	3.41
R-HSA-202403	TCR signaling	116	16	2.75	4.36	0.00021	0.00064	3.1	1.69	5.33
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	83	13	3.12	4.46	0.00023	0.00069	3.58	1.81	6.59
R-HSA-8876725	Protein methylation	19	6	6.3	5.31	0.00024	0.00072	8.83	2.74	25
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	27	7	5.17	4.99	0.00028	0.00085	6.71	2.38	16.6
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	74	12	3.23	4.43	0.00028	0.00085	3.73	1.82	7.05
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	54	10	3.69	4.56	3e-04	0.00089	4.37	1.95	8.88
R-HSA-8878159	Transcriptional regulation by RUNX3	108	15	2.77	4.25	3e-04	9e-04	3.12	1.67	5.46
R-HSA-3371556	Cellular response to heat stress	88	13	2.95	4.21	0.00041	0.0012	3.34	1.69	6.13
R-HSA-5358351	Signaling by Hedgehog	148	18	2.43	4.01	0.00042	0.0012	2.68	1.53	4.46
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	29	7	4.81	4.73	0.00045	0.0013	6.1	2.19	14.9
R-HSA-69618	Mitotic Spindle Checkpoint	112	15	2.67	4.09	0.00045	0.0013	2.99	1.6	5.23
R-HSA-3858494	Beta-catenin independent WNT signaling	137	17	2.48	3.99	0.00048	0.0014	2.74	1.53	4.62
R-HSA-5621481	C-type lectin receptors (CLRs)	138	17	2.46	3.96	0.00052	0.0015	2.72	1.52	4.58
R-HSA-73894	DNA Repair	315	30	1.9	3.73	0.00053	0.0015	2.06	1.35	3.04
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	39	8	4.09	4.44	0.00059	0.0017	4.95	1.96	11.1
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	31	7	4.5	4.49	7e-04	0.002	5.59	2.02	13.4
R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	129	16	2.47	3.87	7e-04	0.002	2.74	1.5	4.69
R-HSA-166208	mTORC1-mediated signalling	23	6	5.2	4.64	0.00075	0.0021	6.75	2.17	18
R-HSA-112382	Formation of RNA Pol II elongation complex 	61	10	3.27	4.09	0.00082	0.0022	3.77	1.7	7.57
R-HSA-75955	RNA Polymerase II Transcription Elongation	61	10	3.27	4.09	0.00082	0.0022	3.77	1.7	7.57
R-HSA-8943724	Regulation of PTEN gene transcription	61	10	3.27	4.09	0.00082	0.0022	3.77	1.7	7.57
R-HSA-8978934	Metabolism of cofactors	16	5	6.23	4.81	0.00086	0.0023	8.68	2.36	27.2
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	41	8	3.89	4.26	0.00083	0.0023	4.65	1.85	10.3
R-HSA-5620920	Cargo trafficking to the periciliary membrane	51	9	3.52	4.14	0.00086	0.0023	4.11	1.75	8.64
R-HSA-379716	Cytosolic tRNA aminoacylation	24	6	4.99	4.49	0.00096	0.0026	6.38	2.06	16.9
R-HSA-168325	Viral Messenger RNA Synthesis	42	8	3.8	4.18	0.00098	0.0026	4.51	1.79	10
R-HSA-3215018	Processing and activation of SUMO	10	4	7.98	5.07	0.001	0.0027	12.7	2.63	53.8
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	74	11	2.96	3.9	0.0011	0.0028	3.36	1.59	6.48
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	17	5	5.87	4.61	0.0012	0.003	7.96	2.19	24.4
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	34	7	4.11	4.17	0.0013	0.0033	4.97	1.82	11.8
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	76	11	2.89	3.79	0.0013	0.0035	3.26	1.54	6.27
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	26	6	4.6	4.23	0.0015	0.0038	5.74	1.88	14.9
R-HSA-429914	Deadenylation-dependent mRNA decay	55	9	3.26	3.87	0.0015	0.0038	3.76	1.61	7.82
R-HSA-8852135	Protein ubiquitination	77	11	2.85	3.74	0.0015	0.0038	3.21	1.52	6.17
R-HSA-73762	RNA Polymerase I Transcription Initiation	45	8	3.55	3.93	0.0016	0.004	4.15	1.66	9.11
R-HSA-2990846	SUMOylation	127	15	2.36	3.53	0.0017	0.0042	2.58	1.39	4.49
R-HSA-4570464	SUMOylation of RNA binding proteins	46	8	3.47	3.86	0.0018	0.0046	4.04	1.62	8.84
R-HSA-110320	Translesion Synthesis by POLH	19	5	5.25	4.26	0.002	0.005	6.82	1.92	20.1
R-HSA-176187	Activation of ATR in response to replication stress	37	7	3.77	3.88	0.0021	0.0053	4.47	1.65	10.4
R-HSA-3371511	HSF1 activation	12	4	6.65	4.5	0.0022	0.0055	9.54	2.09	35.8
R-HSA-9020591	Interleukin-12 signaling	48	8	3.32	3.71	0.0024	0.0059	3.83	1.54	8.36
R-HSA-5617833	Cilium Assembly	201	20	1.98	3.24	0.0026	0.0064	2.14	1.26	3.44
R-HSA-73893	DNA Damage Bypass	49	8	3.26	3.64	0.0028	0.0067	3.74	1.51	8.14
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	21	5	4.75	3.95	0.0032	0.0078	5.97	1.7	17.1
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	30	6	3.99	3.77	0.0033	0.0078	4.78	1.59	12.1
R-HSA-73772	RNA Polymerase I Promoter Escape	30	6	3.99	3.77	0.0033	0.0078	4.78	1.59	12.1
R-HSA-5619115	Disorders of transmembrane transporters	149	16	2.14	3.23	0.0032	0.0078	2.32	1.28	3.95
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	40	7	3.49	3.63	0.0034	0.008	4.06	1.51	9.39
R-HSA-165159	mTOR signalling	40	7	3.49	3.63	0.0034	0.008	4.06	1.51	9.39
R-HSA-5628897	TP53 Regulates Metabolic Genes	86	11	2.55	3.32	0.0036	0.0086	2.82	1.34	5.38
R-HSA-212436	Generic Transcription Pathway	1107	75	1.35	2.85	0.0037	0.0087	1.44	1.1	1.87
R-HSA-73863	RNA Polymerase I Transcription Termination	31	6	3.86	3.66	0.0039	0.0091	4.59	1.53	11.5
R-HSA-379726	Mitochondrial tRNA aminoacylation	14	4	5.7	4.04	0.0042	0.0096	7.63	1.74	26.6
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	14	4	5.7	4.04	0.0042	0.0096	7.63	1.74	26.6
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	32	6	3.74	3.57	0.0046	0.01	4.41	1.48	11
R-HSA-68962	Activation of the pre-replicative complex	32	6	3.74	3.57	0.0046	0.01	4.41	1.48	11
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	65	9	2.76	3.27	0.0049	0.011	3.08	1.33	6.32
R-HSA-159227	Transport of the SLBP independent Mature mRNA	33	6	3.63	3.47	0.0054	0.012	4.25	1.43	10.6
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	33	6	3.63	3.47	0.0054	0.012	4.25	1.43	10.6
R-HSA-4615885	SUMOylation of DNA replication proteins	43	7	3.25	3.39	0.0051	0.012	3.72	1.39	8.53
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	24	5	4.16	3.56	0.006	0.013	5.02	1.46	14
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	67	9	2.68	3.17	0.006	0.013	2.97	1.29	6.09
R-HSA-5633007	Regulation of TP53 Activity	160	16	1.99	2.91	0.0064	0.014	2.14	1.18	3.63
R-HSA-110312	Translesion synthesis by REV1	16	4	4.99	3.67	0.007	0.015	6.36	1.49	21.1
R-HSA-191273	Cholesterol biosynthesis	25	5	3.99	3.44	0.0072	0.016	4.77	1.39	13.2
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	25	5	3.99	3.44	0.0072	0.016	4.77	1.39	13.2
R-HSA-177243	Interactions of Rev with host cellular proteins	35	6	3.42	3.29	0.0072	0.016	3.95	1.34	9.75
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	121	13	2.14	2.91	0.0075	0.016	2.31	1.19	4.16
R-HSA-447115	Interleukin-12 family signaling	58	8	2.75	3.07	0.0079	0.017	3.06	1.25	6.56
R-HSA-72187	mRNA 3'-end processing	58	8	2.75	3.07	0.0079	0.017	3.06	1.25	6.56
R-HSA-141424	Amplification of signal from the kinetochores	96	11	2.29	2.91	0.0084	0.018	2.48	1.19	4.71
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	96	11	2.29	2.91	0.0084	0.018	2.48	1.19	4.71
R-HSA-5655862	Translesion synthesis by POLK	17	4	4.69	3.5	0.0088	0.019	5.87	1.39	19.1
R-HSA-5656121	Translesion synthesis by POLI	17	4	4.69	3.5	0.0088	0.019	5.87	1.39	19.1
R-HSA-201681	TCF dependent signaling in response to WNT	224	20	1.78	2.72	0.0088	0.019	1.89	1.12	3.03
R-HSA-163210	Formation of ATP by chemiosmotic coupling	18	4	4.43	3.35	0.011	0.023	5.45	1.3	17.4
R-HSA-8949613	Cristae formation	18	4	4.43	3.35	0.011	0.023	5.45	1.3	17.4
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	10	3	5.98	3.62	0.012	0.024	8.16	1.36	35.9
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	10	3	5.98	3.62	0.012	0.024	8.16	1.36	35.9
R-HSA-8868766	rRNA processing in the mitochondrion	10	3	5.98	3.62	0.012	0.024	8.16	1.36	35.9
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	39	6	3.07	2.97	0.012	0.025	3.47	1.18	8.45
R-HSA-168276	NS1 Mediated Effects on Host Pathways	39	6	3.07	2.97	0.012	0.025	3.47	1.18	8.45
R-HSA-73884	Base Excision Repair	39	6	3.07	2.97	0.012	0.025	3.47	1.18	8.45
R-HSA-73933	Resolution of Abasic Sites (AP sites)	39	6	3.07	2.97	0.012	0.025	3.47	1.18	8.45
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	19	4	4.2	3.21	0.013	0.027	5.08	1.22	16
R-HSA-176412	Phosphorylation of the APC/C	19	4	4.2	3.21	0.013	0.027	5.08	1.22	16
R-HSA-162588	Budding and maturation of HIV virion	29	5	3.44	3.02	0.014	0.027	3.98	1.18	10.7
R-HSA-5689880	Ub-specific processing proteases	220	19	1.72	2.49	0.015	0.029	1.82	1.06	2.95
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	11	3	5.44	3.38	0.015	0.03	7.14	1.22	29.9
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	11	3	5.44	3.38	0.015	0.03	7.14	1.22	29.9
R-HSA-6790901	rRNA modification in the nucleus and cytosol	11	3	5.44	3.38	0.015	0.03	7.14	1.22	29.9
R-HSA-68689	CDC6 association with the ORC:origin complex	11	3	5.44	3.38	0.015	0.03	7.14	1.22	29.9
R-HSA-8934903	Receptor Mediated Mitophagy	11	3	5.44	3.38	0.015	0.03	7.14	1.22	29.9
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	20	4	3.99	3.07	0.016	0.03	4.77	1.15	14.9
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	20	4	3.99	3.07	0.016	0.03	4.77	1.15	14.9
R-HSA-69186	Lagging Strand Synthesis	20	4	3.99	3.07	0.016	0.03	4.77	1.15	14.9
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	30	5	3.32	2.93	0.016	0.03	3.82	1.14	10.2
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	30	5	3.32	2.93	0.016	0.03	3.82	1.14	10.2
R-HSA-180786	Extension of Telomeres	30	5	3.32	2.93	0.016	0.03	3.82	1.14	10.2
R-HSA-389661	Glyoxylate metabolism and glycine degradation	30	5	3.32	2.93	0.016	0.03	3.82	1.14	10.2
R-HSA-168253	Host Interactions with Influenza Factors	41	6	2.92	2.83	0.016	0.03	3.27	1.12	7.92
R-HSA-6782315	tRNA modification in the nucleus and cytosol	21	4	3.8	2.95	0.019	0.036	4.48	1.09	13.8
R-HSA-1592230	Mitochondrial biogenesis	68	8	2.35	2.56	0.02	0.037	2.55	1.05	5.39
R-HSA-5673001	RAF/MAP kinase cascade	243	20	1.64	2.33	0.02	0.037	1.73	1.03	2.76
R-HSA-180910	Vpr-mediated nuclear import of PICs	32	5	3.12	2.76	0.02	0.038	3.53	1.06	9.36
R-HSA-5656169	Termination of translesion DNA synthesis	32	5	3.12	2.76	0.02	0.038	3.53	1.06	9.36
R-HSA-69231	Cyclin D associated events in G1	44	6	2.72	2.63	0.022	0.04	3.02	1.04	7.24
R-HSA-69236	G1 Phase	44	6	2.72	2.63	0.022	0.04	3.02	1.04	7.24
R-HSA-4551638	SUMOylation of chromatin organization proteins	69	8	2.31	2.51	0.022	0.04	2.51	1.03	5.3
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	57	7	2.45	2.52	0.023	0.042	2.68	1.02	5.97
R-HSA-5688426	Deubiquitination	295	23	1.56	2.22	0.024	0.043	1.63	1.01	2.53
R-HSA-1169408	ISG15 antiviral mechanism	71	8	2.25	2.42	0.025	0.045	2.43	0.999	5.12
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	71	8	2.25	2.42	0.025	0.045	2.43	0.999	5.12
R-HSA-5684996	MAPK1/MAPK3 signaling	249	20	1.6	2.21	0.025	0.045	1.68	0.999	2.69
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	23	4	3.47	2.72	0.026	0.046	4.01	0.989	12.1
R-HSA-70895	Branched-chain amino acid catabolism	23	4	3.47	2.72	0.026	0.046	4.01	0.989	12.1
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	34	5	2.93	2.59	0.026	0.046	3.29	0.99	8.65
R-HSA-195721	Signaling by WNT	314	24	1.52	2.17	0.026	0.046	1.6	0.996	2.45
